<DOC>
	<DOCNO>NCT01055756</DOCNO>
	<brief_summary>The primary objective study evaluate clinical efficacy drug Cloratadd D ® ( loratadine + pseudoephedrine sulfate - EMS S/A ) compare drug Claritin D ® ( loratadine + pseudoephedrine sulfate - Schering Plough ) patient allergic rhinitis quantification score clinical parameter ( sign symptom ) laboratory ( nasal flow ) time .</brief_summary>
	<brief_title>Clinical Trial Of The Effectiveness Of The Product Cloratadd D ( Loratadine + Pseudoephedrine Sulfate ) Produced By The Laboratory EMS S/A , Compared To The Drug Claritin D Produced By Schering-Plough S/A , In Patients With Allergic Rhinitis</brief_title>
	<detailed_description>Secondly , observe safety ( tolerability ) clinic administration drug patient compare clinical parameter incidence adverse event .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>1 . Accept Consent Form . 2 . Age 18 60 year , regardless sex ; 3 . Agree return evaluation study ; 4 . Presenting allergic symptom confirm physical examination laboratory test ( IgE sensitivity mite Dermatophagoides pteronyssinus ) , provide diagnosis allergic rhinitis mild moderate . 1 . Have participate experimental study ingest drug trial 12 month precede start study ; 2 . Made use medication interfere regular response drug 4 week precede start study , steroid antihistamine ; 3 . Be patient sensitivity loratadine / pseudoephedrine sulfate ; 4 . Have disease anatomical abnormality upper airways detrimental analysis data , example , tumor septal deviation moderate severe 5 . Demonstrate history alcohol abuse , drug pharmaceutical . 6 . Have consume alcohol within 48 hour prior period hospitalization ; 7 . Have history liver disease kidney disease ; 8 . Present framework current asthma recent ( less 1 year ) ; 9 . To present severe pressure cause medication ; 10 . Smokers patient stop smoke less 06 month ; 11 . Pregnant nursing woman ; 12 . Patients heart disease use medication cardiovascular system suffer interference drug study , example , βblockers ; 13 . Patients use corticosteroid medicine interact study drug monoamine oxidase ; 14 . Patients history glaucoma , urinary retention , hyperthyroidism ; 15 . Patients undergone facial plastic surgery physician 's discretion , interfere nasal airflow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Reduction sign symptom enhance nasal flow</keyword>
	<keyword>Nasal Flow</keyword>
</DOC>